PharmaCyte Biotech Inc (PMCB)

[styl]

gmc2020 what are you talking about??

if you read the full story it says lincoln park can buy more shares below market value <originally I thought they could sell the shares AT MARKET PRICES>...........If and when when this happens like it did to rgdo this past week.....it can halve a companys stock price....i watched that go from over 12 to 6 to where its trading now for doing a secondary at the 6 dollar price.....and thats 2 weeks after they anounced fast track so go figure that.

another big question is that this analyst pegs sales for pancreatic cancer at 500 mil annually if you also include 5 countries outside the usa.....

and many investors were expecting this to match the "touted" billion dollar a year sales from celgene........

so which figure is correct??

if the total sales market for this pancreatic cancer sales category is 500 mil then the market cap of this company going forward in the near future must be scrutinized.